NewsResearchStill Time To Participate In UK Medical Cannabis Trial

Still Time To Participate In UK Medical Cannabis Trial

-

EUROPE’S largest ever medical cannabis trial is still recruiting patients as it looks to gather further evidence to support its wider adoption.

Known as Project 21, the two-year trial was launched by Britain’s former Drugs Czar Prof David Nutt. He is seeking to recruit 20,000 patients.

Project 21’s partners include the United Patients Alliance and The Royal College of Psychiatrists (RCP), with the aim of creating the largest European medical cannabis body of evidence.

It is being backed by three medical cannabis businesses – Italian company Althea and UK, Firms Alta-Flora and Canuba – who will supply subsidised cannabis medicine.

The trial will focus on a number of conditions including; chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder, Tourette’s syndrome, anxiety disorder or who have had a history of substance misuse.

Patients Are Forced to Break Law

Prof Nutt stated that up until 1971 cannabis had been used as a medicine in the UK for over a century before ‘it was banned for political reasons’

“Since then hundreds of thousands of patients have been forced to break the law to get a treatment that most find preferable to their previous prescription medicines,” he said.

He said Project 21 will provide a ‘solid clinical database from which experience of and confidence in, medical cannabis prescribing will develop, providing a foundation for other medical prescribers to build on’.

Professor Wendy Burn, the RCP president  said it hopes the trial will ‘address the paucity of evidence’ for the use of cannabis-based medicine.

Dr Arun Bhaskar, President of the British Pain Society said some 28m people in the UK will at some stage, suffer from chronic pain.

“Data from several countries reveal that medical cannabis have benefited several thousands of patients,”he added.

Prof Nutt, dismissed by the UK Government for saying alcohol and tobacco are more dangerous to health than ecstasy, LSD and cannabis, went on to form Drugs Science – an independent, science-led drugs charity.

For information on how to participate in the trial visit: https://drugscience.org.uk/project-twenty21/

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Poko Innovations, Inc. Receives Validation And Authorization To Sell 44 Items In The UK

POKO Innovations an award-winning UK-based collection of CBD-focused companies that bring innovative, inspiring solutions to the CBD industry through...

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record quarterly’ results, seeing both revenues and profits skyrocket year-on-year.  Despite its...

Stenocare Delivers First Product Batch To The Danish Market

STENOCARE delivers the first product batch of their THC Oil to the Danish market. This means that the product is...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans for a new £3.5m fundraise alongside a separate £484,000 open...

Cellular Goods Makes More Major Changes To Board In First Update Since Ingestibles Were Pulled (UPDATED)

Cellular Goods has released its first significant update since announcing that its ingestibles products were not legally allowed to...

European Cannabis Stocks Review: Akanda Dives Over 80% & Celadon Suffers After Reporting Huge Rise In Losses

This week was another difficult week for London Stock Exchange (LSE) listed cannabis companies, with every one of BusinessCann's...

Must read

Intercure Posts More Record Results But Says It ‘Could Do So Much More’ If It Had More Supply

INTERCURE has released another set of ‘all time record...

Chill Brands Targets Near £4m Capital Raise To Fund Fresh Strategy & £1.3m Chill.com Domain

CHILL Brands’ shareholders have voted in favour of plans...

You might also likeRELATED
Recommended to you